BX Swiss TOP 30 CHF
1.238,59
PKT
+3,16
PKT
+0,26
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
01.03.05 | Nestlé Overweight | JP Morgan | |
02.03.05 | Swiss Life Hold | Commerzbank | |
01.03.05 | Swisscom Neutral | Helvea | |
01.03.05 | Roche Buy | Sarasin Research | |
28.02.05 | Nestlé Akkumulieren | Independent Research | |
01.03.05 | Swiss Life Outperform | HypoVereinsbank | |
25.02.05 | Holcim In-Line | Goldman Sachs | |
25.02.05 | UBS Buy | Commerzbank | |
25.02.05 | Nestlé In-Line | Goldman Sachs | |
25.02.05 | Holcim Overweight | JP Morgan | |
28.02.05 | Nestlé Buy | Helvea | |
28.02.05 | Nestlé Buy | Sal. Oppenheim | |
28.02.05 | Nestlé Halten | Hamburger Sparkasse | |
25.02.05 | APG SGA Accumulate | Helvea | |
25.02.05 | Givaudan Neutral | Sarasin Research | |
24.02.05 | Novartis Overweight | Lehman Brothers | |
24.02.05 | Holcim Verkaufen | Helaba Trust | |
24.02.05 | Nestlé Buy | Helvea | |
25.02.05 | Nestlé Neutral | Sarasin Research | |
25.02.05 | Nestlé Outperform | Credit Suisse First Boston | |
25.02.05 | Nestlé Hold | SEB | |
23.02.05 | UBS Buy | Sarasin Research | |
24.02.05 | Zurich Insurance Accumulate | Helvea | |
25.02.05 | Givaudan Underperform | Credit Suisse First Boston | |
22.02.05 | Holcim Buy | Dresdner Kleinwort Wasserstein | |
22.02.05 | ABB (Asea Brown Boveri) Accumulate | Helvea | |
22.02.05 | Novartis Buy | Helvea | |
23.02.05 | Zurich Insurance Hold | Dresdner Kleinwort Wasserstein | |
22.02.05 | ABB (Asea Brown Boveri) Halten | Hamburger Sparkasse | |
23.02.05 | Novartis Outperform | Goldman Sachs | |
21.02.05 | Straumann Outperform | Goldman Sachs | |
21.02.05 | Nestlé Equal weight | Lehman Brothers | |
21.02.05 | Novartis Neutral | Sarasin Research | |
22.02.05 | Swiss Life Neutral | UBS | |
22.02.05 | Zurich Insurance Halten | Helaba Trust | |
23.02.05 | ABB (Asea Brown Boveri) Overweight | Lehman Brothers | |
22.02.05 | Nestlé Kaufen | Helaba Trust | |
21.02.05 | Novartis Buy | Helvea | |
23.02.05 | Nestlé Overweight | JP Morgan | |
22.02.05 | Novartis Akkumulieren | Independent Research |